Profit and value who will drive-.doc

 PAGE \* MERGEFORMAT 10 Profit and value who will drive? In 2008 the pharmaceutical industry, as China’s A share market, the shock adjustment, crazy fall at the same time it also breeds new hope. Some strength, a clear positioning enterprises will wind through the stock adjustment quickly occupied the relevant channels and markets, in order to achieve their own take-off. Of course, whether it is more than 6,000 domestic pharmaceutical production-oriented enterprises, or nearly ten thousand commercial companies, there will be a large number of enterprises have been eliminated such bumps. While we, as always, the future of China’s pharmaceutical markets are working well, but how to deal with the current market competition and development, or we must carefully study. In fact, careful study of the pharmaceutical companies currently on the market, no wonder that two of the factors in the guidelines for the development of enterprises: ‘profit-driven’ and ‘value-driven’. Taken literally the only word to see different ideas, but it has created two entirely different businesses: one is a simple fast track approach and the pursuit of profit-maximizing enterprises, their business ideas focus on immediate results are always ups and downs in the operation, there is no smooth development path to speak of, and gradually move toward decline; and those are always the pursuit of ‘century-old’ mode of operation of the business, focusing on brand building and market intensive, although not a short-term inputs and outputs, the ideal ratio, but the competition in the market turmoil and circumstances, the more show the company’s nature of resistance and good earnings performance in the market. These two very different living conditions of the emergence of the enterprise, it is the role of the two guiding ideology the results, it is worth our consideration. 1, ‘profit-driven’: Figure 1 o’clock fast foot the bill for the future The fundamental business is the pursuit of profit, th